Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Acquisitions (2023 - 2025)

Privia Health has reported Acquisitions over the past 3 years, most recently at $91.3 million for Q4 2025.

  • For Q4 2025, Acquisitions rose 1360.99% year-over-year to $91.3 million; the TTM value through Dec 2025 reached $180.4 million, up 2492.64%, while the annual FY2025 figure was $180.4 million, 2492.64% up from the prior year.
  • Acquisitions for Q4 2025 was $91.3 million at Privia Health, up from $89.1 million in the prior quarter.
  • Over five years, Acquisitions peaked at $91.3 million in Q4 2025 and troughed at $707000.0 in Q1 2024.
  • A 3-year average of $32.9 million and a median of $13.0 million in 2023 define the central range for Acquisitions.
  • Biggest five-year swings in Acquisitions: tumbled 97.16% in 2024 and later soared 1360.99% in 2025.
  • Year by year, Acquisitions stood at $5.0 million in 2023, then rose by 25.0% to $6.2 million in 2024, then soared by 1360.99% to $91.3 million in 2025.
  • Business Quant data shows Acquisitions for PRVA at $91.3 million in Q4 2025, $89.1 million in Q2 2025, and $6.2 million in Q4 2024.